Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-22-033477

Director sold 1,126 shares at an average $55.32 ($62,291)

  • Director acquired 626 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BOLGER JOHN C Director 2022-05-31 Option exercise +313 $3.93 $1,229 4,313 D: show line 1 in the form
BOLGER JOHN C Director 2022-05-31 Sale −313 $55.32 $17,315 4,000 D: show line 2 in the form
BOLGER JOHN C Director 2022-05-31 Option exercise +313 $5.81 $1,818 4,313 D: show line 3 in the form
BOLGER JOHN C Director 2022-05-31 Sale −313 $55.44 $17,351 4,000 D: show line 4 in the form
BOLGER JOHN C Director 2022-05-31 Sale −500 $55.25 $27,625 3,500 D: show line 5 in the form
Open-market sales · 1,126 sh · avg $55.32 · $62,291

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BOLGER JOHN C Director 2022-05-31 Option exercise · Stock Option (Right to Buy) −313 0 D: show line 6 in the form
BOLGER JOHN C Director 2022-05-31 Option exercise · Stock Option (Right to Buy) −313 1,250 D: show line 7 in the form
Loading xslF345X03/doc4.xml…